ATE323466T1 - Nitroimidazole enthaltende gelzusammensetzung - Google Patents

Nitroimidazole enthaltende gelzusammensetzung

Info

Publication number
ATE323466T1
ATE323466T1 AT97950300T AT97950300T ATE323466T1 AT E323466 T1 ATE323466 T1 AT E323466T1 AT 97950300 T AT97950300 T AT 97950300T AT 97950300 T AT97950300 T AT 97950300T AT E323466 T1 ATE323466 T1 AT E323466T1
Authority
AT
Austria
Prior art keywords
nitroimidazoles
composition containing
gel composition
water
skin
Prior art date
Application number
AT97950300T
Other languages
English (en)
Inventor
Michael Goodman
Ake Lindahl
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10804765&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE323466(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Sa filed Critical Galderma Sa
Application granted granted Critical
Publication of ATE323466T1 publication Critical patent/ATE323466T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Colloid Chemistry (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97950300T 1996-12-20 1997-12-19 Nitroimidazole enthaltende gelzusammensetzung ATE323466T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9626513.7A GB9626513D0 (en) 1996-12-20 1996-12-20 A pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE323466T1 true ATE323466T1 (de) 2006-05-15

Family

ID=10804765

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97950300T ATE323466T1 (de) 1996-12-20 1997-12-19 Nitroimidazole enthaltende gelzusammensetzung

Country Status (17)

Country Link
US (1) US6348203B1 (de)
EP (1) EP0946143B1 (de)
JP (1) JP2001507018A (de)
KR (1) KR20000069606A (de)
AT (1) ATE323466T1 (de)
AU (1) AU730812B2 (de)
CA (1) CA2275429A1 (de)
DE (1) DE69736998T2 (de)
DK (1) DK0946143T3 (de)
ES (1) ES2263183T3 (de)
GB (1) GB9626513D0 (de)
IE (1) IES970906A2 (de)
NO (1) NO992980L (de)
NZ (1) NZ336258A (de)
PT (1) PT946143E (de)
WO (1) WO1998027960A2 (de)
ZA (1) ZA9711455B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2232855C (en) * 1997-04-10 2007-10-09 Roche Consumer Health (Worldwide) Sa Pharmaceutical formulation
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
EP1206937B1 (de) * 1999-07-16 2008-01-23 Shoei Co., Ltd. Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
JP2002212073A (ja) * 2001-01-15 2002-07-31 Shoei:Kk 水性液剤
SE0103528D0 (sv) 2001-10-21 2001-10-21 Jan Faergeman Topiska kompositioner med förstärkt effekt
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
SE0301862D0 (sv) * 2003-06-26 2003-06-26 Jan Faergeman Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
US7456207B2 (en) * 2003-09-25 2008-11-25 Teva Pharmaceuticals Usa, Inc. Vaginal pharmaceutical compositions and methods for preparing them
FR2866570B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter une inflammation cutanee
FR2866569B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter des pathologies liees au recepteur de type b de l'interleukine 8 et/ou au recepteur de type 1 de pacap
FR2866568B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter un desordre de la vascularisation cutanee
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
EP2359808B1 (de) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotisches Verabreichungssystem mit Kolbenanordnung
US8258164B2 (en) * 2006-09-12 2012-09-04 Curatek Pharmaceuticals Holding, Inc. Nitroimidazole composition and method
JP5238295B2 (ja) * 2007-03-09 2013-07-17 第一三共ヘルスケア株式会社 低刺激性透明半固形外用剤
WO2008133908A2 (en) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
DE102008006394A1 (de) * 2008-01-28 2009-07-30 Beiersdorf Ag Verwendung von Wirkstoffkomplexen aus Panthenol, Glycerin, Citrat und/oder Bisabolol gegen Pollenallergien
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US20100105750A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
RU2547990C2 (ru) 2009-09-28 2015-04-10 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
CN106913902A (zh) 2009-11-09 2017-07-04 聚光灯技术合伙有限责任公司 多糖基水凝胶
CN102695501A (zh) 2009-11-09 2012-09-26 聚光灯技术合伙有限责任公司 碎裂水凝胶
WO2012009794A1 (en) * 2010-07-19 2012-01-26 Brusells Ventures Corp. Antimicrobial medical gel composition comprising etherified hydroxyethylcellulose
JP5954928B2 (ja) * 2010-11-19 2016-07-20 大同化成工業株式会社 皮膚潰瘍処置用外用剤のゲル状基剤
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
AU2012275292B2 (en) 2011-06-28 2015-11-12 Chemo Research, S.L. High dosage mucoadhesive metronidazole aqueous-based gel formulations their use to treat bacterial vaginosis
WO2014100569A1 (en) * 2012-12-20 2014-06-26 Medicis Pharmaceutical Corporation High dosage topical metronidazole gel formulations
EP3013368A1 (de) 2013-06-25 2016-05-04 Mission Pharmacal Company Neuartige formulierungen zur behandlung von vaginalen erkrankungen
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
RU2730996C2 (ru) 2015-06-03 2020-08-26 Интарсия Терапьютикс, Инк. Системы установки и извлечения имплантата
AU2016344349B2 (en) * 2015-10-25 2022-05-19 Iview Therapeutics, Inc. Pharmaceutical formulations that form gel in situ
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
JP7286542B2 (ja) 2017-01-03 2023-06-05 インターシア セラピューティクス，インコーポレイティド Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421443C2 (de) * 1984-06-08 1996-09-05 Daicel Chem Stabile Gelmasse und Verfahren zu ihrer Herstellung
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
EP0386960A3 (de) * 1989-03-07 1991-10-23 American Cyanamid Company Pharmazeutische Zusammensetzungen zur Verwendung als Wirkstoffabgabevehikel und/oder als Wundverband
GB2229443A (en) * 1989-03-07 1990-09-26 American Cyanamid Co Wound dressings
CA1337279C (en) * 1989-06-06 1995-10-10 Robert J. Borgman Intravaginal treatment of vaginal infections with buffered metronidazole compositions
EP0564586B1 (de) * 1990-12-21 2002-03-20 BOMBART, Felice Wässrige vaginaldusche und deren anwendung
GB9105995D0 (en) * 1991-03-21 1991-05-08 Smith & Nephew Wound dressing
US5662924A (en) * 1991-03-21 1997-09-02 Smith & Nephew Plc Wound dressing
SE506509C2 (sv) * 1992-04-14 1997-12-22 Bioglan Ab Användning av imidazoler för framställning av en farmaceutisk formulering för behandling av inflammatoriska och/eller infektiösa hudsjukdomar
US5391367A (en) * 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution

Also Published As

Publication number Publication date
ZA9711455B (en) 1998-09-02
NO992980L (no) 1999-08-16
PT946143E (pt) 2006-08-31
KR20000069606A (ko) 2000-11-25
AU5330898A (en) 1998-07-17
EP0946143A2 (de) 1999-10-06
DE69736998T2 (de) 2007-03-01
CA2275429A1 (en) 1998-07-02
GB9626513D0 (en) 1997-02-05
WO1998027960A2 (en) 1998-07-02
IES80590B2 (en) 1998-10-07
JP2001507018A (ja) 2001-05-29
ES2263183T3 (es) 2006-12-01
EP0946143B1 (de) 2006-04-19
AU730812B2 (en) 2001-03-15
IES970906A2 (en) 1998-10-07
DE69736998D1 (de) 2007-01-04
US6348203B1 (en) 2002-02-19
NO992980D0 (no) 1999-06-17
DK0946143T3 (da) 2006-08-21
WO1998027960A3 (en) 1998-09-11
NZ336258A (en) 2001-04-27

Similar Documents

Publication Publication Date Title
ATE323466T1 (de) Nitroimidazole enthaltende gelzusammensetzung
ATE163863T1 (de) Gelwundverbandszusammensetzungen und verfahren zu deren gebrauch
AR002944A1 (es) Uso de una composicion de gel acuosa que contiene una o mas drogas que son eficaces para tratar hemorroides para la preparacion de un medicamento y dicha composicion de gel acuosa
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
EP0640647A3 (de) Ionisch vernetzte Gele aus Glykosaminoglykan zur Vermehrung von Weichgewebe und Arzneimittelabgabe.
BR0008787A (pt) Sistema à base de colágeno injetável para aplicação de células ou agentes terapêuticos
ATE274900T1 (de) Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels
DK1248613T3 (da) Clonidinpræparater
ATE209900T1 (de) Wachsumsfaktoren enthaltende gelformulierungen
DE69728678T2 (de) Hydrokolloid-wundgel
DE60103894D1 (de) Sprühfähige wundversorgungszusammensetzung
ATE290397T1 (de) Formulierung fur die wundheilung mit menschlichem plasma fibronektin
RU96124095A (ru) Применение геля в качестве протравителя
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
DE3773383D1 (de) Neue topische metronidazol-formulierungen.
ATE240094T1 (de) Ophthalmische zusammensetzungen in form wässriger gele
FR2542616B1 (fr) Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
FR2782922B1 (fr) Composition contenant de l'uree et ses utilisations dans le domaine cosmetique et/ou dermatologique
FR2719475B1 (fr) Composition cosmétique et/ou dermatologique à gélifiant polymérique cationique, ses utilisations notamment pour la dépigmentation de la peau.
PT1140001E (pt) Composicao para tratamento de queimaduras
AR017170A1 (es) Composicion oftalmologica
TH9143A (th) ส่วนประกอบของเจบทาแผลและวิธีการใช้
ES281238U (es) Parche antiarrugas y-o para los cuidados de la piel
GT199600070A (es) Composicion de gel cosmetica teniendo irritacion de la piel reducida.
NO912521L (no) Saargelblandinger og fremgangsmaater for anvendelse av disse

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0946143

Country of ref document: EP